Science Explorer Back to mapMap

Most cited papers from Ospedale Papa Giovanni XXIII

What are the most cited papers from Ospedale Papa Giovanni XXIII?

The most cited paper from Ospedale Papa Giovanni XXIII is "Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy" (Giacomo Grasselli et al., 2020), with 5,912 citations. Next come "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure" (5,214) and "Organoid Models and Applications in Biomedical Research" (3,519).

Showing 50 of 60 papers. Every paper with more than 521 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy Giacomo Grasselli et al. · JAMA Open access114 authors 6 Apr 2020 5,912
2 Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Milton Packer et al. · New England Journal of Medicine Open access 28 Aug 2020 5,214
3 Organoid Models and Applications in Biomedical Research Christodoulos Xinaris, Valerio Brizi, Giuseppe Remuzzi · ˜The œNephron journals/Nephron journals Open access 2015 3,519
4 ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem et al. · Annals of Oncology Open access 5 Jul 2016 3,512
5 COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Behnood Bikdeli et al. · Journal of the American College of Cardiology Open access 17 Apr 2020 2,956
6 International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber et al. · Blood Open access 29 Jun 2022 2,906
7 The Global Burden of Cancer 2013 Christina Fitzmaurice et al. · JAMA Oncology Open access132 authors 28 May 2015 2,767
8 Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer Gϋnter von Minckwitz et al. · New England Journal of Medicine Open access 5 Dec 2018 2,689
9 Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma Nikhil C. Munshi et al. · New England Journal of Medicine Open access 24 Feb 2021 2,554
10 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Lucio Verdoni, Angelo Mazza, Annalisa Gervasoni et al. · The Lancet Open access 13 May 2020 2,488
11 Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Scott David Solomon et al. · New England Journal of Medicine Open access Sep 2019 2,429
12 Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma Jeffrey S. Weber et al. · New England Journal of Medicine Open access 10 Sep 2017 2,249
13 ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 Jecko V. Thachil, Ning Tang, Satoshi Gando et al. · Journal of Thrombosis and Haemostasis Open access 25 Mar 2020 2,014
14 Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma Alexander M.M. Eggermont et al. · New England Journal of Medicine Open access 15 Apr 2018 1,906
15 Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Charles S. Fuchs et al. · JAMA Oncology Open access 15 Mar 2018 1,835
16 Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy Giacomo Grasselli et al. · JAMA Internal Medicine Open access149 authors 15 Jul 2020 1,747
17 The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions Roderick J. Hay, Nicole E. Johns, Hywel C Williams et al. · Journal of Investigative Dermatology Open access 28 Oct 2013 1,710
18 Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer et al. · Journal of Clinical Oncology Open access 5 Aug 2019 1,517
19 Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma Georgina Venetia Long et al. · New England Journal of Medicine Open access 10 Sep 2017 1,501
20 Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study Luca Carsana, Aurelio Sonzogni, Ahmed Medhat Nasr et al. · The Lancet Infectious Diseases Open access 8 Jun 2020 1,441
21 Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Roberto Labianca, Bernard Nordlinger, Giordano Domenico Beretta et al. · Annals of Oncology Open access 27 Sep 2013 1,428
22 Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial Georgina Venetia Long et al. · The Lancet 31 May 2015 1,419
23 Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma Caroline Robert et al. · New England Journal of Medicine Open access 4 Jun 2019 1,412
24 Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis Pietro Amedeo Modesti, Gianpaolo Reboldi, Francesco Paolo Cappuccio et al. · PLoS ONE ReviewOpen access 25 Jan 2016 1,405
25 Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Guillem Argilés, Josep M. Tabernero, Roberto Labianca et al. · Annals of Oncology Open access 20 Jul 2020 1,399
26 Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Kohei Shitara et al. · The Lancet Open access158 authors 4 Jun 2018 1,338
27 Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study Max S. Topp et al. · The Lancet Oncology 15 Dec 2014 1,277
28 International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology Ravindra L. Mehta et al. · The Lancet 13 Mar 2015 1,164
29 Duration of Adjuvant Chemotherapy for Stage III Colon Cancer Axel F. Grothey et al. · New England Journal of Medicine Open access 28 Mar 2018 1,155
30 Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial Andrew J Davidson et al. · The Lancet Open access 5 Nov 2015 1,136
31 Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors 8 Jul 2021 1,130
32 Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial Reinhard Dummer, Paolo A. Ascierto, Helen J Gogas et al. · The Lancet Oncology Open access 21 Mar 2018 1,040
33 Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial Paolo A. Ascierto et al. · The Lancet Oncology 30 Jul 2016 1,027
34 Chronic kidney disease Paola Romagnani, Giuseppe Remuzzi, Richard J. Glassock et al. · Nature Reviews Disease Primers ReviewOpen access 22 Nov 2017 1,008
35 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Christopher J L Murray et al. · The Lancet Open access366 authors 21 Jul 2014 998
36 Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome Vittorio Pengo et al. · Blood Open access 12 Jul 2018 821
37 Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions Lorenz Räber et al. · European Heart Journal Open access 16 May 2018 763
38 Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Olivia Pagani et al. · New England Journal of Medicine Open access Jun 2014 756
39 Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson et al. · Blood Open access 18 Jul 2014 746
40 Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan et al. · JAMA Open access Sep 2015 707
41 Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer Prudence A. Francis et al. · New England Journal of Medicine Open access 4 Jun 2018 694
42 Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic Lorenzo D’Antiga · Liver Transplantation 20 Mar 2020 686
43 Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study Georgina Venetia Long et al. · Annals of Oncology Open access 3 May 2017 668
44 Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study Bogdan Ene‐Iordache et al. · The Lancet Global Health Open access 21 Apr 2016 665
45 Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial Ziad A. Ali, Akiko Maehara, Philippe Généreux et al. · The Lancet 30 Oct 2016 663
46 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection Anthony Jake Demetris et al. · American Journal of Transplantation Open access 7 Jun 2016 653
47 The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger et al. · Blood Cancer Journal Open access 9 Feb 2018 650
48 Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013 Hmwe Hmwe Kyu et al. · Archives of Pediatrics and Adolescent Medicine Open access157 authors 26 Jan 2016 641
49 PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Zhaohui Gu et al. · Nature Genetics Open access 7 Jan 2019 631
50 COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study Marina Chiara Garassino et al. · The Lancet Oncology Open access 12 Jun 2020 624

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.